Kestrel Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PINC
Premier
PINC
|
+$5.31M |
| 2 |
Shoals Technologies Group
SHLS
|
+$5.09M |
| 3 |
Upwork
UPWK
|
+$4.92M |
| 4 |
Prestige Consumer Healthcare
PBH
|
+$2.83M |
| 5 |
Forrester Research
FORR
|
+$1.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tenet Healthcare
THC
|
+$9.08M |
| 2 |
DT Midstream
DTM
|
+$7.6M |
| 3 |
Integra LifeSciences
IART
|
+$2.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.91% |
| 2 | Technology | 24.08% |
| 3 | Healthcare | 14.17% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Energy | 7.09% |
Similar funds
Kestrel Investment Management's Q3 2024 Portfolio in Review
As of Q3 2024, Kestrel Investment Management held 42 positions worth $174M, up 15% from $151M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Kestrel Investment Management deployed $10.2M of net new capital in Q3 2024, opening 5 new positions and adding to 32 existing holdings. Its largest new stake was Premier: 267,350 shares worth $5.24M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Tenet Healthcare, an estimated $9.08M trimmed.
- Kestrel Investment Management's largest Q3 2024 buy was Premier: 267,350 shares worth $5.24M.
- Kestrel Investment Management added most to Prestige Consumer Healthcare in Q3 2024, an estimated $2.83M increase.
- Kestrel Investment Management's biggest Q3 2024 reduction was Tenet Healthcare, cutting an estimated $9.08M.
- Kestrel Investment Management fully exited DT Midstream in Q3 2024, selling an estimated $7.6M.
- Kestrel Investment Management's ten largest holdings make up 42% of its $174M portfolio in Q3 2024.
- Kestrel Investment Management opened 5 new positions and closed 2 in Q3 2024.
- Kestrel Investment Management's portfolio value rose 15% quarter-over-quarter to $174M.
Based on Kestrel Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.